Actonel
$ 187,00 – $ 230,00Price range: $ 187,00 through $ 230,00
Actos
$ 52,00 – $ 239,00Price range: $ 52,00 through $ 239,00
Actoplus Met
$ 43,00 – $ 343,00Price range: $ 43,00 through $ 343,00
Actoplus Met is an effective oral medication designed to help adults manage type 2 diabetes by combining two powerful active ingredients. This formula contains pioglitazone and metformin, which work together to improve the body’s response to insulin and decrease the amount of sugar produced by the liver. By maintaining stable blood glucose levels, this medication helps prevent long-term complications associated with high blood sugar. It is typically used alongside a balanced diet and regular exercise program to achieve optimal glycemic control. Actoplus Met provides a convenient dual-action approach for individuals seeking to maintain their metabolic health and overall well-being.
Active substance: metformin, Pioglitazone
SKU:
Actoplus Met
Category: Diabetes
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Actoplus Met belongs to a combination class of oral antidiabetic agents that pair pioglitazone, a thiazolidinedione, with metformin, a biguanide. It is prescribed as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. This prescription-only medication is evaluated under federal standards set by the U.S. Food and Drug Administration (FDA).
Understanding the safety profile, potential warnings, and administration instructions is critical when managing your treatment plan. Always follow your healthcare provider’s directions precisely to minimize serious risks associated with therapy.
| Drug Name | Actoplus Met |
| Active Ingredients | Pioglitazone hydrochloride / Metformin hydrochloride |
| Prescription Status | Prescription only (Rx) |
| Dosage Form | Oral tablet |
| Primary Purpose | Glycemic control in type 2 diabetes mellitus |
| Route of Administration | Oral |
Clinical Overview and Safety Profile
Important Precautions and Warning Signs
Important Precautions: Warning: Actoplus Met carries boxed warnings due to risks of serious adverse reactions. The metformin component poses a risk of lactic acidosis, a rare but potentially fatal metabolic emergency characterized by elevated blood lactate levels. Risk factors for metformin-associated lactic acidosis include renal impairment, age 65 or older, radiological contrast procedures, surgical interventions, hypoxic states, and excessive alcohol intake. The pioglitazone component can cause or exacerbate congestive heart failure. Initiation is contraindicated in patients with established New York Heart Association (NYHA) Class III or IV heart failure. Monitor all patients for signs of heart failure, such as rapid weight gain or peripheral edema. Therapy should be avoided in severe hepatic impairment, and kidney function (eGFR) must be evaluated prior to initiation and periodically thereafter.
Adverse Reactions: Adverse reactions associated with Actoplus Met combine the safety profiles of its individual active components. Frequent complaints include upper respiratory tract infections, headache, weight gain, edema, diarrhea, nausea, flatulence, and abdominal discomfort. Gastrointestinal side effects are primarily tied to metformin and often diminish over time. Serious side effects require immediate clinical evaluation. These include severe peripheral edema, onset or worsening of heart failure, hypoglycemia (particularly when co-administered with insulin or insulin secretagogues such as sulfonylureas), bone fractures in female patients, macular edema leading to visual impairment, and an increased risk of urinary bladder cancer associated with long-term pioglitazone exposure.
Red Flags: Warning: You must seek immediate emergency medical care if you experience symptoms indicating severe adverse complications. Lactic acidosis requires urgent emergency treatment; signs include unusual muscle pain, trouble breathing, severe stomach discomfort, feeling cold in arms or legs, dizziness, lightheadedness, or an abnormally slow heart rate. Immediate care is also required if you develop signs of heart failure, such as sudden weight gain, swelling of the feet or lower legs, or trouble breathing while lying down.
| Warning Sign | Potential Complication | Required Action |
|---|---|---|
| Severe fatigue, muscle pain, difficulty breathing | Lactic Acidosis | Seek immediate emergency care |
| Rapid weight gain, swelling in legs or feet | Congestive Heart Failure | Contact prescriber immediately |
| Yellowing of skin or eyes, dark urine | Hepatic Impairment | Stop medication and seek medical care |
| Visual changes or blurry vision | Macular Edema | Consult eye specialist or provider |
Mechanism of Action and Pharmacokinetics
How the Drug Works: Actoplus Met combines two antihyperglycemic agents with complementary mechanisms of action to improve glycemic control. Pioglitazone is a thiazolidinedione that acts as a selective agonist for peroxisome proliferator-activated receptor-gamma (PPAR-gamma). Activation of nuclear PPAR-gamma receptors alters the transcription of genes involved in glucose and lipid metabolism, resulting in increased insulin sensitivity in peripheral tissues (skeletal muscle and adipose tissue) and reduced hepatic glucose output. Metformin is a biguanide that decreases hepatic gluconeogenesis, decreases intestinal absorption of glucose, and enhances peripheral glucose uptake. Neither component stimulates pancreatic beta-cell insulin secretion, meaning the combination does not directly induce hyperinsulinemia.
How It’s Absorbed and Eliminated: Following oral administration, pioglitazone is rapidly absorbed, achieving peak plasma concentrations within 2 hours. Food slightly delays peak concentration but does not alter total absorption. Pioglitazone is extensively bound to serum proteins (>99%) and undergoes hepatic metabolism primarily via CYP2C8 and CYP3A4, producing active metabolites that are excreted mainly through bile and feces. Metformin has an absolute oral bioavailability of approximately 50% to 60% under fasting conditions. Metformin does not bind to plasma proteins and is not metabolized by the liver; it is eliminated unchanged by renal excretion via glomerular filtration and tubular secretion. The plasma elimination half-life of metformin is approximately 6.2 hours.
Main Uses: Actoplus Met is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both pioglitazone and metformin is appropriate. It is not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it relies on the presence of endogenous insulin to exert its therapeutic effects. Usage must be determined by a qualified healthcare professional after careful evaluation of cardiovascular and renal status.
Dosing, Interactions, and Daily Guidelines
Dosing, Administration, and Missed Doses
Dosing Schedule: The dosage of Actoplus Met must be individualized based on the patient’s current treatment regimen, therapeutic response, and tolerability. It is available in fixed-dose combination oral tablets (such as 15 mg pioglitazone / 850 mg metformin hydrochloride or 15 mg pioglitazone / 1000 mg metformin hydrochloride). The maximum recommended daily dosage is 45 mg of pioglitazone and 2550 mg of metformin hydrochloride. Therapy should be initiated at a lower dose and gradually titrated to reduce gastrointestinal adverse effects. Renal function must be checked via estimated glomerular filtration rate (eGFR) before starting treatment.
If You Skip a Dose: If you miss a dose, take it with your next scheduled meal. If it is almost time for your next regular dose, skip the missed dose entirely and resume your normal schedule. Never take two doses at the same time or take extra medicine to make up for a missed dose, as doubling up increases the risk of adverse gastrointestinal events and hypoglycemia.
What to Avoid While Taking It: Warning: Avoid excessive acute or chronic alcohol consumption while taking Actoplus Met. Alcohol potentiates the effect of metformin on lactate metabolism, significantly increasing the risk of life-threatening lactic acidosis. Additionally, avoid taking the medication on an empty stomach; administering tablets with food minimizes gastrointestinal side effects such as nausea, diarrhea, and stomach cramps.
What Not to Combine: Actoplus Met has significant potential for drug-drug interactions. Concomitant use with iodinated contrast media used in imaging procedures can precipitate acute renal failure and lactic acidosis; medication must be temporarily discontinued prior to or at the time of the procedure. Co-administration with strong CYP2C8 inhibitors (such as gemfibrozil) increases pioglitazone serum levels, requiring a dose reduction of the pioglitazone component. Conversely, CYP2C8 inducers (such as rifampin) can decrease pioglitazone concentrations. Cationic drugs eliminated by renal tubular secretion (e.g., ranitidine, digoxin) may compete for transport systems with metformin, altering elimination. Carbonic anhydrase inhibitors (such as topiramate) increase the risk of lactic acidosis.
Day-to-Day Use: Managing therapy requires routine clinical monitoring. Patients should regularly self-monitor blood glucose levels as directed by their provider. Hemoglobin A1c (HbA1c) testing should be performed periodically to evaluate long-term glycemic control. Renal function (eGFR) and liver enzyme levels must be checked before starting therapy and at least annually thereafter. Female patients should be aware of fracture risks, and routine eye exams are advised to check for macular edema.
Common Questions (FAQ)
Why must Actoplus Met be taken with meals?
Taking Actoplus Met with food helps minimize common gastrointestinal side effects associated with metformin, such as nausea, stomach upset, and diarrhea. Food slows absorption slightly, improving digestive tolerance without reducing the medication’s therapeutic effectiveness.
What precautions are necessary before undergoing an X-ray or CT scan with contrast dye?
You must inform your doctor immediately if you are scheduled for an imaging procedure requiring iodinated contrast media. Metformin can interact with contrast dye to cause sudden renal failure and lactic acidosis. Prescribers typically instruct patients to temporarily stop taking Actoplus Met prior to or at the time of the procedure and restart only after renal function has been re-evaluated and confirmed stable.
Is weight gain expected during Actoplus Met therapy?
Yes, weight gain can occur while taking Actoplus Met. This effect is primarily related to the pioglitazone component, which promotes fluid retention and adipose tissue accumulation. While metformin often has a weight-neutral or slight weight-reducing effect, the net result in combination therapy may still be weight gain. Unusually rapid weight gain should be reported immediately, as it may indicate fluid retention associated with heart failure.
How does alcohol affect safety while on Actoplus Met?
Alcohol alters metabolic pathways in the liver and significantly heightens the risk of metformin-induced lactic acidosis, a life-threatening medical emergency. Both acute binge drinking and chronic heavy alcohol intake must be strictly avoided during treatment with Actoplus Met.
Can Actoplus Met cause low blood sugar (hypoglycemia)?
When used alone, Actoplus Met carries a low risk of hypoglycemia because neither active ingredient directly stimulates pancreatic insulin secretion. However, the risk of low blood sugar increases substantially if Actoplus Met is combined with insulin or insulin secretagogues, such as sulfonylureas. Your prescriber may adjust doses of co-administered antidiabetic drugs to prevent hypoglycemic episodes.
In accordance with FDA requirements.
This material is educational. Only a licensed prescriber can determine whether a medication is appropriate for you.
Additional information
| Dosage |
15mg+500mg |
|---|---|
| Package |
30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία | , |
Related products
Actos
$ 52,00 – $ 239,00Price range: $ 52,00 through $ 239,00
Active substance: Pioglitazone
More Details
This product has multiple variants. The options may be chosen on the product page
DDAVP spray
$ 64,00 – $ 412,00Price range: $ 64,00 through $ 412,00
Active substance: Desmopressin acetate
More Details
This product has multiple variants. The options may be chosen on the product page
Forxiga
$ 52,00 – $ 340,00Price range: $ 52,00 through $ 340,00
Active substance: Dapagliflozin
More Details
This product has multiple variants. The options may be chosen on the product page
Glucophage Trio
$ 96,00 – $ 187,00Price range: $ 96,00 through $ 187,00
More Details
This product has multiple variants. The options may be chosen on the product page
Glucotrol XL
$ 14,00 – $ 170,00Price range: $ 14,00 through $ 170,00
Active substance: Glipizide
More Details
This product has multiple variants. The options may be chosen on the product page
Glucovance
$ 48,00 – $ 342,00Price range: $ 48,00 through $ 342,00
Active substance: glibenclamide, metformin
More Details
This product has multiple variants. The options may be chosen on the product page
Glycomet
$ 4,00 – $ 71,00Price range: $ 4,00 through $ 71,00
Active substance: metformin
More Details
This product has multiple variants. The options may be chosen on the product page
Metformin
$ 33,00 – $ 190,00Price range: $ 33,00 through $ 190,00
Active substance: metformin
More Details
This product has multiple variants. The options may be chosen on the product page
